Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

bicalutamide MeSH Supplementary Concept Data 2025


MeSH Supplementary
bicalutamide
Unique ID
C053541
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C053541
Entry Term(s)
4'-cyano-3-(4-fluorophenylsulfonyl)-2-hydroxy-2-methyl-3'-(trifluoromethyl)propionanilide
Casodex
Cosudex
ICI 176334
ICI-176334
Pharm Action
Androgen Antagonists
Antineoplastic Agents
Registry Numbers
A0Z3NAU9DP
Related Numbers
90357-06-5
CAS Type 1 Name
Propanamide, N-(4-cyano-3-(trifluoromethyl)phenyl)-3-((4-fluorophenyl)sulfonyl)-2-hydroxy-2-methyl-, (+-)-
Heading Mapped to
*Anilides
*Nitriles
*Tosyl Compounds
Frequency
1208
Note
approved for treatment of advanced prostate cancer
Source
J Endocrinol 1987;113(3):R7
Date of Entry
1987/10/09
Revision Date
2016/12/22
bicalutamide Preferred
Casodex Narrower
ICI-176334 Narrower
page delivered in 0.002s